GGrantIndex
Sort

59,101 grants matching hypertension

Defining the role of early pulmonary vascular disease in COPD

$790,711
Eric A Hoffman · University Of Iowa · R01 · FY2015 · HL

Clinical, Genetic, and Proteomic Risk Factors for Pulmonary Hypertension in Heart Failure

$790,627
Evan L Brittain · Vanderbilt University Medical Center · R01 · FY2020 · HL

Vascular Imaging Biomarker Relationships to Alzheimer’s disease (VIBRA)

$790,491
Mohamad Habes · University Of Texas Hlth Science Center · R01 · FY2024 · AG

Cellular And Molecular Pathogenesis Of Alzheimer

$790,462
Mark Mattson · National Institute On Aging · ZIA · FY2013 · AG

Action for Health in Diabetes Brain Magnetic Resonance Imaging Ancillary Study

$790,366
Mark Andrew Espeland · Wake Forest University Health Sciences · R01 · FY2011 · DK

The Mechanical Basis of Primary Open Angle Glaucoma

$790,295
Mark Johnson · Northwestern University · R01 · FY2015 · EY

Intersection of Material-Need Insecurities and HIV and Cardiovascular Health

$790,151
Sheri Dawn Weiser · University Of California, San Francisco · R01 · FY2021 · HL

A daily diary examination of the influence of anticipated and vicarious stressors on blood pressure

$790,087
Billy A Caceres · Columbia University Health Sciences · R01 · FY2025 · HL

Risk stratification in pulmonary arterial hypertension: Intersection of OMICs and longitudinal phenotypes through the PAH Biobank

$789,984
William C Nichols · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · HL

An endothelial-fibroblast axis connecting senescence to amino acid metabolism for control of vascular stiffness in PAH

$789,976
Stephen Y Chan · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · HL

The Mechanical Basis of Primary Open Angle Glaucoma

$789,854
Mark Johnson · Northwestern University · R01 · FY2010 · EY

Counseling older Americans to control hypertension (COACH)

$789,757
Gbenga Godwin Ogedegbe · Columbia University Health Sciences · P60 · FY2012 · MD

A Hybrid Type 1 Effectiveness-Implementation Study of Social Incentives Strategies to Increase Physical Activity

$789,732
Karen Glanz · University Of Pennsylvania · R01 · FY2021 · HL

Ion Channels and Membrane Receptors in Pulmonary Arterial Hypertension

$789,719
Jason X.-J. Yuan · University Of California, San Diego · R35 · FY2022 · HL

Ion Channels and Membrane Receptors in Pulmonary Arterial Hypertension

$789,719
Jason X.-J. Yuan · University Of California, San Diego · R35 · FY2023 · HL

Genes of Hypertension in African Americans

$789,690
Medical College Of Wisconsin · R01 · FY2004 · HL

Lung Function Decline and Disease Risk from Young Adulthood to Middle Age

$789,672
Ravi Kalhan · Northwestern University At Chicago · R01 · FY2016 · HL

Pulmonary Hypertension in Left Heart Disease

$789,618
Margaret M Redfield · Mayo Clinic Rochester · R01 · FY2025 · HL

Understanding causal mechanisms in preeclampsia through genetic instrumental variables

$789,510
Ayush Giri · Vanderbilt University Medical Center · R01 · FY2022 · HL

Elucidating the Role of Adipokines in Mediating and Predicting HF Associated with Obesity

$789,451
Chiadi E Ndumele · Johns Hopkins University · R01 · FY2021 · HL

Renal Denervation in Heart Failure with Preserved Ejection Fraction

$789,349
Traci Taylor Goodchild · Cedars-Sinai Medical Center · R01 · FY2024 · HL

Net Lifetime Health Effects of Alcohol Use &Abuse

$789,347
Boston University Medical Campus · R01 · FY2005 · AA

Minding the gap: a multidisciplinary approach to reducing maternal health disparities in Georgia

$789,294
Denise Jean Jamieson · Emory University · R01 · FY2020 · MD

Gut microbial metabolites and risk of coronary heart disease: a prospective, multiethnic, metabolomic study

$789,290
Danxia Yu · Vanderbilt University Medical Center · R01 · FY2021 · HL

An endothelial-fibroblast axis connecting senescence to amino acid metabolism for control of vascular stiffness in PAH

$789,261
Stephen Y Chan · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HL